Nick Sutcliffe - October 3, 2023 Covid autumn booster vaccine 2023: the switch to mono-valent vaccines Autumn 2023 sees another round of COVID-19 booster jabs across the UK for vulnerable people.
Nick Sutcliffe - December 20, 2022 mRNA cancer vaccine shows efficacy in clinical trial Moderna and Merck announced in a mid-December 2022 press release that its mRNA cancer vaccine ...
Tanis Keirstead - April 14, 2022 Horizons in vaccine production The scramble for a coronavirus vaccine over the last two years has demonstrated how important ...
Tanis Keirstead - April 4, 2022 A much-needed boost: the future of coronavirus vaccines Just over two years after our first blog on Covid-19, it appears that the disease is here to stay. ...
Camille Terfve - November 12, 2021 Digital therapeutics: the rise of digital health technologies during the Covid-19 pandemic There is no denying that the Covid-19 pandemic has reshaped many aspects of our lives. Those lucky ...
Samuel Hart - June 3, 2021 Healthy eating means more than just a balanced diet: future foods and fighting the risk of infection Human health is inextricably linked to food – not least because eating a healthy diet is known to ...
Nathan Zhang - May 4, 2021 A sense of hope with graphene-based COVID-19 detection With mass COVID-19 vaccinations being rolled out by countries across the world, there may be an end ...
Joseph Newcombe - April 26, 2021 COVID-19 win for AI pharma farmers The vaccine roll-out is in action all over the world. Nevertheless, given the propensity of ...
Sarah Harvey - March 23, 2021 EPO 2020 Patent Index - key trends The European Patent Office (EPO) recently published its 2020 Patent Index which provides a ...
Adam Gregory - January 29, 2021 SARS-CoV-2 variants – reasons to be optimistic In recent weeks and months, several highly-transmissible variants of SARS-CoV-2 (the virus that ...
Eliot Ward - December 21, 2020 Will the COVID-19 vaccines induce more robust immunity than infection with SARS-Cov-2 itself? Respiratory viruses such as coronaviruses are notorious for evading the immune system[1] and, in ...
Nick Sutcliffe - November 25, 2020 AstraZeneca/Oxford University vaccine shows efficacy against SARS-CoV-2 AstraZeneca/Oxford University have announced that their SARS-CoV-2 candidate vaccine AZD1222 showed ...
Joseph Newcombe - November 19, 2020 Protective barriers against COVID-19 – what’s behind the screen? Since the outbreak of the COVID-19 pandemic there has been a significant increase in the demand for ...
Nick Sutcliffe - November 16, 2020 And then there were two – Moderna SARS-CoV-2 vaccine shows efficacy Moderna have announced that their SARS-CoV-2 vaccine candidate mRNA1273 showed efficacy in a first ...
Nick Sutcliffe - November 13, 2020 Pfizer and BioNTech vaccine provides protection against SARS-CoV-2 Pfizer/BioNTech have now released more data from the Phase 3 clinical trial of the BNT162b2 ...
Emma Kennaugh-Gallacher - November 6, 2020 COVID-19 rescue act or major overhaul of the UK insolvency framework? As we go into England’s second national lockdown of this COVID-19 pandemic, greater numbers of ...
Adam Gregory - October 27, 2020 Hummingbird Bioscience to start clinical trials for SARS-CoV-2-targeted antibody, HMBD-115 Our client, Hummingbird Bioscience, has received regulatory authorisation to initiate clinical ...
Kate O'Rourke - September 15, 2020 Facing facts: How the rise of face coverings has brought IP risks Forward: features discuss and celebrate the best of innovation and exploration from the scientific ...
Melodie Richardson - September 4, 2020 Combatting COVID-19: does Vitamin D have a role to play? Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), better known as COVID-19 or simply ...
Kate O'Rourke - August 11, 2020 Team Home or Team Office: the challenges of a COVID-19 secure workplace Solicitor Hilda-Georgina Kwafo-Akoto discusses how the COVID-19 pandemic could be a catalyst for ...
Rachel Oxley - July 9, 2020 “Test, test, test” – the importance of diagnostics in pandemic preparedness While the world waits for a vaccine to be developed and approved for use against the COVID-19 ...
Jacqueline Pang - June 26, 2020 Industry makeover: how the cosmetics industry has been affected by COVID-19 The cosmetics industry has undergone a major transformation during the ongoing COVID-19 crisis. ...
Rebecca Tollervey - June 25, 2020 Cellular immunity – a contributor to COVID-19 “dark matter”? Immunologist Karl Friston of University College London has theorized that there may be ...
Sean Constable - June 10, 2020 Can CRISPR help us in the fight against COVID-19? As countries across the world continue to face widespread disruption in the face of the COVID-19 ...
Foteini Tzakoniati - June 5, 2020 Links between COVID-19 severity and the immune system The mechanism through which SARS-CoV-2, the virus that causes COVID-19, infects cells is known. The ...
Rebecca Anderson-Smith - June 5, 2020 Branding in times of crisis: It’s time to make your mark meaningful David Benady explains why a brand based on solid values is now a business’s most powerful asset.
Julie Carlisle - June 1, 2020 Is faster drug development likely to become the “new normal?” As part of our Thought Leaders series, Sarah Kostiuk-Smith explores whether faster drug development ...
Willum Wytenburg - May 29, 2020 COVID-19: Suspension of Surcharge for Late Payment of Renewal Fees at the EPO The European Patent Office (EPO) now has a dedicated webpage regarding their response to COVID-19; ...
Alex Burns - May 28, 2020 Contact tracing – our route out of the coronavirus (COVID-19) lockdown? It appears that the United Kingdom is now past the peak of the COVID-19 infection curve, and the ...
Frederick Steele - May 22, 2020 Electronic signatures, “the new normal”? The COVID-19 pandemic and resulting social distancing has meant that in-person signing of documents ...
Adam Gregory - May 15, 2020 New coronavirus (COVID-19) test allows rapid detection of neutralising antibodies Our client, Duke-NUS, has helped to develop a new, rapid serological test for determining whether ...
Simon Parry - May 12, 2020 From airbags to medical gowns – Autoliv continues to save lives to help fight against coronavirus (COVID-19) Companies around the world are pivoting to help meet global shortages of personal protection ...
Kate O'Rourke - May 6, 2020 Counterfeit contagion: fraudulent activities spread amid coronavirus (COVID-19) The COVID-19 outbreak has caused disruption to manufacturing operations on a global scale. Lockdown ...
Stephen Gill - May 1, 2020 How computer modelling has been used during the coronavirus (COVID-19) outbreak to inform political decisions Throughout the emergence and continued spread of the novel coronavirus, COVID-19, policy makers ...
Willum Wytenburg - May 1, 2020 Coronavirus (COVID-19) extension at the EPO: Part 2 The European Patent Office (EPO) now has a dedicated webpage regarding their response to COVID-19; ...
Robert Andrews - April 30, 2020 BerGenBio’s bemcentinib selected for fast track as potential treatment for coronavirus (COVID-19) In the fight against the coronavirus pandemic, bemcentinib produced by BerGenBio has been selected ...
Rebecca Anderson-Smith - April 30, 2020 The power of trade marks: social distancing logos during the coronavirus (COVID-19) pandemic We are all now familiar with the social distancing guidelines set out by the World Health ...
Genevieve Pugh - April 28, 2020 Graphene masks: facing up to coronavirus (COVID-19) Since the development and isolation of graphene by researchers at Manchester University in 2004, ...
Rebecca Anderson-Smith - April 27, 2020 Temporary modification of production conditions for PGIs and PDOs will help farmers struggling to deal with coronavirus (COVID-19) The coronavirus lockdowns across many European countries have brought a variety of new challenges ...
Andrew Pitts - April 24, 2020 Governments look to protect companies from IP enforcement during the coronavirus (COVID-19) pandemic A large effort is underway globally to ensure that there are enough mechanical ventilators ...
Camille Terfve - April 23, 2020 Coronavirus (COVID-19), big data and silver linings There is no denying that the COVID-19 pandemic will have tremendous practical and economic impact ...
Tom Furnival - April 22, 2020 How 3D printing is helping in the fight against coronavirus (COVID-19) In a crisis which has been defined by its pace of change, 3D printing has become a useful tool in ...
Julie Carlisle - April 20, 2020 Has a cure for coronavirus (COVID-19) already been made? Faced with the biggest global pandemic in most of our lifetimes, all around the world research ...
Adam Gregory - April 14, 2020 Antibody tests for prior infection with SARS-CoV-2 – key tools for monitoring and managing the coronavirus (COVID-19) outbreak In recent weeks there’s been a lot of discussion in the media of antibody tests relating to ...
Matthew Naylor - April 9, 2020 Crown Use during the coronavirus (COVID-19) pandemic As discussed in a previous blog, the UK Government has the power to authorise (either in advance, ...
Rebecca Anderson-Smith - April 9, 2020 Why a "COVID-19” trade mark should be rejected The COVID-19 pandemic has undoubtedly forced us all to adapt our lives and business practices in ...
Camille Terfve - April 6, 2020 What use is computational biology during the coronavirus (COVID-19) pandemic? There is one obvious way in which computational biology is showing its strengths in the current ...
Jacqueline Murphy - April 3, 2020 3D printing community responds to the coronavirus (COVID-19) challenge The coronavirus (COVID19) pandemic has left healthcare systems globally scrambling for much needed ...
Andrew Pitts - April 3, 2020 Patent infringement during a national emergency: a Coronavirus (COVID-19) perspective Recent interesting reports highlight an emerging practice borne out of necessity in which medical ...
Eliot Ward - April 2, 2020 A*STAR and MiRXES step up in the fight against coronavirus (COVID-19) Our Singapore based-clients A*STAR (Agency for Science, Technology and Research) and MiRXES are ...
Tanis Keirstead - March 24, 2020 Coronavirus (COVID-19): a case study in emerging disease UPDATE 14 APRIL 2022: In his blog Horizons in vaccine production, we explore pressing need to ...
Lucy White - March 23, 2020 Vaccine platform technologies to combat emerging infectious diseases The SARS-CoV-2 outbreak is now a global pandemic. In a previous post, we discussed the need to act ...
Richard Clegg - March 20, 2020 Changes to our correspondence address In response to the current situation in London due to Coronavirus (COVID-19) we are redirecting all ...
Willum Wytenburg - March 16, 2020 Coronavirus (COVID-19) Extension at the EPO: Not ALL deadlines extended! Part 2 of this blog was published on 17 April 2020. Please read for the latest information. News ...
